Selective mGAT2 (BGT-1) GABA Uptake Inhibitors: Design, Synthesis, and Pharmacological Characterization

被引：32
|
作者：
Vogensen, Stine B. [1 ]
Jorgensen, Lars [1 ]
Madsen, Karsten K. [1 ]
Borkar, Nrupa [1 ]
Wellendorph, Petrine [1 ]
Skovgaard-Petersen, Jonas [1 ]
Schousboe, Arne [1 ]
White, H. Steve [2 ]
Krogsgaard-Larsen, Povl [1 ]
Clausen, Rasmus P. [1 ]
机构：
[1] Univ Copenhagen, Fac Hlth & Med Sci, Dept Drug Design & Pharmacol, DK-2100 Copenhagen, Denmark
[2] Univ Utah, Dept Pharmacol & Toxicol, Anticonvulsant Drug Dev Program, Salt Lake City, UT 84112 USA
来源：
JOURNAL OF MEDICINAL CHEMISTRY | 2013年 / 56卷 / 05期
关键词：
MOLECULAR PHARMACOLOGY; ANTICONVULSANT ACTION; FUNCTIONAL-ROLE; TRANSPORTERS; TIAGABINE; MECHANISMS; DRUGS;
D O I：
10.1021/jm301872x
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
beta-Amino acids sharing a lipophilic diaromatic side chain were synthesized and characterized pharmacologically on mouse GABA transporter subtypes mGAT1-4. The parent amino acids were also characterized. Compounds 13a, 13b, and 17b displayed more than 6-fold selectivity for mGAT2 over mGAT1. Compound 17b displayed anticonvulsive properties inferring a role of mGAT2 in epileptic disorders. These results provide new neuropharmacological tools and a strategy for designing subtype selective GABA transport inhibitors.
引用
收藏
页码：2160 / 2164
页数：5
相关论文
共 50 条
  • [41] Vicinal diaryl pyrazole with tetrazole/urea scaffolds as selective angiotensin converting enzyme-1/cyclooxygenase-2 inhibitors: Design, synthesis, anti-hypertensive, anti-fibrotic, and anti-inflammatory
    Fadaly, Wael A. A.
    Elshaier, Yaseen A. M. M.
    Ali, Fares E. M.
    El-Bahrawy, Ali H.
    Abdellatif, Khaled R. A.
    Nemr, Mohamed T. M.
    DRUG DEVELOPMENT RESEARCH, 2024, 85 (04)
  • [42] Synthesis, characterization and pharmacological evaluation of some new 1,3,4-oxadiazole derivatives bearing 3-chloro-2-fluoro phenyl moiety
    Bhat, Manjunatha
    Nagaraja, G. K.
    Kayarmar, Reshma
    Raghavendra, S. V.
    Rajesh, K. P.
    Manjunatha, H.
    RESEARCH ON CHEMICAL INTERMEDIATES, 2016, 42 (12) : 7771 - 7792
  • [43] Design and chemical synthesis of [1,2,4]triazol[1,5-c]pyrimidin-5-yl amines, a novel class of VEGFR-2 kinase inhibitors
    Kiselyov, Alexander S.
    Chekler, Eugene L. Piatnitski
    Chernisheva, Natalia B.
    Salamandra, Lev K.
    Semenov, Victor V.
    TETRAHEDRON LETTERS, 2009, 50 (27) : 3809 - 3812
  • [44] Design, molecular docking and synthesis of novel 5,6-dichloro-2-methyl-1H-benzimidazole derivatives as potential urease enzyme inhibitors
    Mentese, Emre
    Emirik, Mustafa
    Sokmen, Bahar Bilgin
    BIOORGANIC CHEMISTRY, 2019, 86 : 151 - 158
  • [45] Design and Synthesis of 2-Heterocyclyl-3-arylthio-1H-indoles as Potent Tubulin Polymerization and Cell Growth Inhibitors with Improved Metabolic Stability
    La Regina, Giuseppe
    Bai, Ruoli
    Rensen, Willeke
    Coluccia, Antonio
    Piscitelli, Francesco
    Gatti, Valerio
    Bolognesi, Alessio
    Lavecchia, Antonio
    Granata, Ilaria
    Porta, Amalia
    Maresca, Bruno
    Soriani, Alessandra
    Iannitto, Maria Luisa
    Mariani, Marisa
    Santoni, Angela
    Brancale, Andrea
    Ferlini, Cristiano
    Dondio, Giulio
    Varasi, Mario
    Mercurio, Ciro
    Hamel, Ernest
    Lavia, Patrizia
    Novellino, Ettore
    Silvestri, Romano
    JOURNAL OF MEDICINAL CHEMISTRY, 2011, 54 (24) : 8394 - 8406
  • [46] Optimization of pyrazole/1,2,4-triazole as dual EGFR/COX-2 inhibitors: Design, synthesis, anticancer potential, apoptosis induction and cell cycle analysis
    Kahk, Nesma M.
    Mohamed, Fatma E. A.
    Abdelhakeem, Marwa M.
    Bakr, Rania B.
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2025, 287
  • [47] Design and Synthesis of Novel Ibuprofen Derivatives as Selective COX-2 Inhibitors and Potential Anti-Inflammatory Agents: Evaluation of PGE2, TNF-α, IL-6 and Histopathological Study
    Halim, Peter Amir
    El-Nassan, Hala Bakr
    El-Dash, Yara Sayed
    MEDICINAL CHEMISTRY, 2022, 18 (04) : 427 - 443
  • [48] Pharmacological Characterization of 2-Methyl-N-((2′-(pyrrolidin-1-ylsulfonyl)biphenyl-4-yl)methyl)propan-1-amine (PF-04455242), a High-Affinity Antagonist Selective for κ-Opioid Receptors
    Grimwood, S.
    Lu, Y.
    Schmidt, A. W.
    Vanase-Frawley, M. A.
    Sawant-Basak, A.
    Miller, E.
    McLean, S.
    Freeman, J.
    Wong, S.
    McLaughlin, J. P.
    Verhoest, P. R.
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2011, 339 (02) : 555 - 566
  • [49] Design, synthesis, and biological evaluation of 3-amino-2-oxazolidinone derivatives as potent quorum-sensing inhibitors of Pseudomonas aeruginosa PAO1
    Jiang, Kai
    Yan, Xinlin
    Yu, Jiahao
    Xiao, Zijian
    Wu, Hao
    Zhao, Meihua
    Yue, Yuandong
    Zhou, Xiaoping
    Xiao, Junhai
    Lin, Feng
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2020, 194
  • [50] Design, Synthesis and Biological Evaluation of Novel 4-(4-Methoxynaphthalen-1-yl)-5-arylpyrimidin-2-amines as Tubulin Polymerization Inhibitors
    Liu, Wenjing
    Wang, Guangcheng
    Peng, Zhiyun
    Li, Yongjun
    CHEMICAL & PHARMACEUTICAL BULLETIN, 2020, 68 (12) : 1184 - 1192
12345